PharMerica, Inc. Announces Results of Offer to Purchase
VALLEY FORGE, Pa.--(BUSINESS WIRE)--Nov. 2, 2001--PharMerica, Inc., a wholly-owned subsidiary of AmerisourceBergen Corporation (NYSE:ABC), today announced that no Notes were tendered in response to its offer to purchase its 8.375% Senior Subordinated Notes due in 2008.
The offer, which commenced on September 28, 2001 and expired on October 29, 2001, was required under the applicable indenture as a result of the merger of AmeriSource Health Corporation and Bergen Brunswig Corporation on August 29, 2001. A total of $123.5 million principal amount of these Notes remain outstanding.
About AmerisourceBergen Corporation
AmerisourceBergen is the largest pharmaceutical services company in the United States dedicated solely to the pharmaceutical supply chain. It is the leading distributor of pharmaceutical products and services to the hospital systems/acute care market, alternative care facilities, independent community pharmacies, and regional drugstore chains.
AmerisourceBergen is also a leader in the institutional pharmacy marketplace. With approximately $36 billion in annualized operating revenues, AmerisourceBergen is headquartered in Valley Forge, PA, and employs more than 13,000 people serving over 25,000 customers.
This press release may contain certain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may vary materially from the expectations contained in the forward-looking statements. The forward-looking statements herein include statements addressing future financial and operating results of AmerisourceBergen and the benefits and other aspects of the merger.
The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: the risk that the businesses of AmeriSource and Bergen Brunswig will not be integrated successfully; failure to obtain and retain expected synergies; and other economic, business, competitive and/or regulatory factors affecting the business of AmerisourceBergen generally.
More detailed information about these factors is set forth in AmeriSource's and Bergen Brunswig's filings with the Securities and Exchange Commission, including each of their Annual Reports on Form 10-K for fiscal 2000, their most recent quarterly reports on Form 10-Q, and their joint proxy statement-prospectus dated August 1, 2001.
AmerisourceBergen, AmeriSource and Bergen Brunswig are under no obligation to (and expressly disclaim any such obligation to) update or alter their forward-looking statements whether as a result of new information, future events or otherwise.
|CONTACT:||AmerisourceBergen Corporation, Valley Forge|
|Michael N. Kilpatric, 610/727-7118|